Related Articles
Pharmacokinetic analysis for the differentiation of pituitary microadenoma subtypes through dynamic contrast‑enhanced magnetic resonance imaging
Contrast-enhanced dynamic and diffusion-weighted magnetic resonance imaging at 3.0 T to assess early-stage nasopharyngeal carcinoma
Grading of pancreatic neuroendocrine neoplasms using pharmacokinetic parameters derived from dynamic contrast‑enhanced MRI
Application evaluation of DCE‑MRI combined with quantitative analysis of DWI for the diagnosis of prostate cancer
Quantitative analysis of permeability for glioma grading using dynamic contrast‑enhanced magnetic resonance imaging